| 摘要 |
<p>The present invention relates to peptides for use in immunotherapy of tumors, in particular renal cell carcinoma's. The peptides are derived from the amino acid sequence of a renal cell carcinoma-associated antigen, called the G250 protein. A particularly preferred peptide has the amino acid sequence: HLSTAFARV. The peptides of the invention may be formulated into pharmaceutical composition for administration to humans or animals. Alternatively, the peptides may be administered to a human or animal in conjunction with an antigen presenting cell, or they may be encoded on a gene therapy agent to be expressed by the human or animal.</p> |
